RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCOPUS

      NCl-H157 폐암 세포주에서 Caspase Cascade 활성을 통한 Arsenic Trioxide와 Sulindac 병합요법의 세포고사 효과 = Inducing Apoptosis of NCl-H157 Humman Lung Carcinoma Cells via Activation of Caspase Cascade by Combination Treatment with ArsenicTrioxide and Sulindac

      한글로보기

      https://www.riss.kr/link?id=A104548136

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Arsenic trioxide(As2O3) was introduced into the treatment of refractory or relapsed acute promyelocytic leukemia. Some investigators have reported that arsenic trioxide had induced apoptosis in a variety of solid human tumor cell lines, including non-small cell lung cancer. Non-steroidal anti-inflammatory drugs(NSAIDs) are powerful chemopreventive agents for gastrointestinal cancers and the growth of established tumors are reduced by inducing apoptosis. It's also reported that NSAIDs enhanced tumor response to chemotherapeutic drugs or radiation. In this study, we aimed to determine whether combination of arsenic trioxide with sulindac augmented its apoptotic potential in NCI-H157 human lung cancer cells. The human lung cancer cell line NCI-H157 was treated with arsenic trioxide and sulindac. Cell viability was measured by the MTT assay. Apoptosis was measured by nuclear staining and flow cytometric analysis. The catalytic activity of the caspase families were measured by the fluorogenic cleavage of biosubstrates. The western blotting were also performed to define the mechanical basis of apoptosis.Combination treatment of arsenic trioxide and sulindac decreased the viability of NCI-H157 human lung cancer cells in a dose-dependent manner. The catalytic activity of caspase-3, 8 and 9 proteases were increased after combination treatment. Consistently PARP was cleaved from 116kDa to 85kDa fragments, and the expression of ICAD was decreased by time-dependent manner. Also combination treatment increased the expression of Fas and Fas/L.Combination therapy of arsenic trioxide with sulindac augments cell death and induces apoptosis via the activation of caspase cascade in NCI-H157 human lung carcinoma cells.(Tuberculosis and Respiratory Diseases 2004, 56:381-392)
      번역하기

      Arsenic trioxide(As2O3) was introduced into the treatment of refractory or relapsed acute promyelocytic leukemia. Some investigators have reported that arsenic trioxide had induced apoptosis in a variety of solid human tumor cell lines, including non-...

      Arsenic trioxide(As2O3) was introduced into the treatment of refractory or relapsed acute promyelocytic leukemia. Some investigators have reported that arsenic trioxide had induced apoptosis in a variety of solid human tumor cell lines, including non-small cell lung cancer. Non-steroidal anti-inflammatory drugs(NSAIDs) are powerful chemopreventive agents for gastrointestinal cancers and the growth of established tumors are reduced by inducing apoptosis. It's also reported that NSAIDs enhanced tumor response to chemotherapeutic drugs or radiation. In this study, we aimed to determine whether combination of arsenic trioxide with sulindac augmented its apoptotic potential in NCI-H157 human lung cancer cells. The human lung cancer cell line NCI-H157 was treated with arsenic trioxide and sulindac. Cell viability was measured by the MTT assay. Apoptosis was measured by nuclear staining and flow cytometric analysis. The catalytic activity of the caspase families were measured by the fluorogenic cleavage of biosubstrates. The western blotting were also performed to define the mechanical basis of apoptosis.Combination treatment of arsenic trioxide and sulindac decreased the viability of NCI-H157 human lung cancer cells in a dose-dependent manner. The catalytic activity of caspase-3, 8 and 9 proteases were increased after combination treatment. Consistently PARP was cleaved from 116kDa to 85kDa fragments, and the expression of ICAD was decreased by time-dependent manner. Also combination treatment increased the expression of Fas and Fas/L.Combination therapy of arsenic trioxide with sulindac augments cell death and induces apoptosis via the activation of caspase cascade in NCI-H157 human lung carcinoma cells.(Tuberculosis and Respiratory Diseases 2004, 56:381-392)

      더보기

      참고문헌 (Reference)

      1 Chen CJ, "genecity of high-arsenicartesian well water Multiple risk factors and related malignant neoplasm of blackfoot disease" 452-60, sclerosis1988

      2 Everson RB, "dence in a prospective study" Scheinemachers DM 138-46, epidemiology1994

      3 Chen GQ, "Use of arsenic trioxide (As2O3) in the treatment of acute promyeꠀlcytic leukemia(APL) I. As2O3 exerts dose- dependent dual effects on APL cells" 89 : 3345-3353, 1997

      4 Soignet SL, "United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemi" 19 : 3852-3860, 2001

      5 Sun HD, "Treatment of acute promyelocytic leukemia by Ailing-1 therapy with use of syndrome differentiation of traditional Chinese medicine" 12 : 170-1, 1992

      6 Soriano AF, "Synergistic effects of new chemopreventive agents and conventional cytotoxic agents against human lung cancer cell lines" 59 : 6178-6184, 1999

      7 Shiff SJ, "Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenoꠀcarcinoma cells" 96 (96): 491-503, 1995

      8 Klampfer L, "Sodium salicylate activates caspases and induces apoptosis of myeloid leukemia cell lines" 93 : 2386-2394, 1999

      9 Koki AT, "Potential utility of COX-2 inhibitors in chemopreꠀvention and chemotherapy" 8 : 1623-1638, 1999

      10 Harris RE, "Nonsteroidal antiinflammatory drugs and breꠀast cancer" 7 : 203-205, 1996

      1 Chen CJ, "genecity of high-arsenicartesian well water Multiple risk factors and related malignant neoplasm of blackfoot disease" 452-60, sclerosis1988

      2 Everson RB, "dence in a prospective study" Scheinemachers DM 138-46, epidemiology1994

      3 Chen GQ, "Use of arsenic trioxide (As2O3) in the treatment of acute promyeꠀlcytic leukemia(APL) I. As2O3 exerts dose- dependent dual effects on APL cells" 89 : 3345-3353, 1997

      4 Soignet SL, "United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemi" 19 : 3852-3860, 2001

      5 Sun HD, "Treatment of acute promyelocytic leukemia by Ailing-1 therapy with use of syndrome differentiation of traditional Chinese medicine" 12 : 170-1, 1992

      6 Soriano AF, "Synergistic effects of new chemopreventive agents and conventional cytotoxic agents against human lung cancer cell lines" 59 : 6178-6184, 1999

      7 Shiff SJ, "Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenoꠀcarcinoma cells" 96 (96): 491-503, 1995

      8 Klampfer L, "Sodium salicylate activates caspases and induces apoptosis of myeloid leukemia cell lines" 93 : 2386-2394, 1999

      9 Koki AT, "Potential utility of COX-2 inhibitors in chemopreꠀvention and chemotherapy" 8 : 1623-1638, 1999

      10 Harris RE, "Nonsteroidal antiinflammatory drugs and breꠀast cancer" 7 : 203-205, 1996

      11 Chan TA, "Mechanism underlying nonsteroidal antiinflammatory drug-mediated apoptosis" 95 : 681-686, 1998

      12 Huang S, "Induction of mitosis-mediated apoptosis by sodium arseꠀnite in Hela S3 cells" 60 : 771-780, 2000

      13 Zhang TC, "Induction of apoptosis and inhibition of huꠀman gastric cancer MGC-803 cell growth by arsenic trioxide" 35 : 1258-1263, 1999

      14 Chen GQ, "In vitro studies on cellular and molecular mechanisms of arsenic trioxide in the treatment of acute promyelocytic leuꠀkemia: arsenic trioxide induces NB4 cell apoptosis with downregualation of Bcl-2 expression and modulation of PML-RAR/PML proteins" 88 : 1052-1061, 1996

      15 Milas L, "Enhancement of tumor response to gamma-radiation by an inhibitor of cyclooxygenase-2 enzyme" 91 : 1501-1504, 1999

      16 Duffy CP, "Enhancement of chemotherapeutic drug toxicity to human tumour cells in vitro by a subset of NSAIDs" 34 : 1250-1259, 1998

      17 Seol JG, "Effect of arsenic trioxide on cell cycle arrest in head and neck cancer cell line PCI-1" 265 : 400-404, 1999

      18 Hida T, "Cyclooxyꠀgenase-2 inhibitor induces apoptosis and enhances cytotoxicity of various anticancer agents in non-small cell lung cancer cell lines" 6 : 2006-2011, 2000

      19 Milas L, "Cyclooxygenase-2 (COX-2) enzyme inhibitors as potential enhancers of tumor radioresponse" 11 : 290-299, 2001

      20 Torrance CJ, "Combinatorial chemoprevention of intestinal neoplasia" 6 : 1024-1028, 2000

      21 Smalley WE, "Colorectal cancer and non-steroidal anti-inflammatory drugs" 39 : 1-20, 1997

      22 Dannenberg AJ, "Chemoprevention of colon-rectal cancer through inhibition of cyclooxygenase-2" 26 : 499-504, 1999

      23 Chen CJ, "Cancer potential in liver,lung,bladder and kidney due to ingested inorganic arsenic in drinking water" 66 : 888-92, 1992

      24 Thun MJ, "Aspirin use and reduced risk of fatal colon cancer" 325 : 1593-6, 1991

      25 Jung BH, "Arseꠀnic trioxide induces apoptosis of HL-60 cells via activation of intrinsic caspase protease with mitochondrial dysfunction" 34 : 308-315, 2002

      26 Uslu R, "Arsenic trioꠀxide-mediated cytotoxicity and apoptosis in prostate and ovarian carcinoma cell lines" 6 : 4957-4964, 2000

      27 Park WH, "Arsenic trioxide-mediated growth inhibition in MC/CAR myeloma cells via cell cycle arrest in association with induction of cyclin-dependent kinase inhibiꠀtor, p21, and apoptosis" 60 : 3065-3071, 2000

      28 Ling YH, "Arsenic trioxide produces polymerization of microtubules and mitotic arrest before apoptosis in human tumor cell lines" 62 : 529-538, 2002

      29 Shen ZY, "Arsenic trioxide induces apoptosis of oesophageal carcinoma in vitro" 4 : 33-37, 1999

      30 Akao Y, "Arsenic trioxide induces apoptosis in neuroblastoma cell lines through the activation of caspase 3 in vitro" 445 : 59-62, 1992

      31 Zheng J, "Arsenic trioxide incuces apoptosis of HPV16 DNA-immortalized human cervical epithelial cells and selectively inhibits viral gene expression" 82 : 286-292, 1999

      32 Cohen JJ, "Apoptosis:the physiologic pathway of cell death" 28 : 35-43, 1993

      33 Williams GT, "Apoptosis in the immune system" 173 : 1-4, 1994

      더보기

      동일학술지(권/호) 다른 논문

      동일학술지 더보기

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2011-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2009-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2007-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2004-07-30 학술지명변경 한글명 : 결핵 및 호흡기질환 -> Tuberculosis and Respiratory Diseases KCI등재
      2004-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2003-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2002-01-01 평가 등재후보학술지 유지 (등재후보1차) KCI등재후보
      2000-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.21 0.21 0.2
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.19 0.15 0.475 0.2
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼